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Abstract 
 
Background/Aim. Kidney injury molecule-1 (KIM-1) and aq-
uaporin-1 (AQP-1) are potential early urinary biomarkers of clear 
renal cell carcinoma (cRCC). The aim of this study was to ascer-
tain relationship between the urine concentrations KIM-1 and 
AQP-1 with tumor size, grade, pT stage and type of operation 
(radical or partial nephrectomy) in patients with cRCC. Methods. 
Urinary concentrations of urinary KIM-1 (uKIM-1) and urinary 
AQP-1 (uAQP-1) were determined by commercially available 
ELISA kits. The analysis included 40 patients undergoing partial 
or radical nephrectomy for cRCC and 40 age- and sex-matched 
healthy adult volunteers. Results. The median preoperative con-
centrations of KIM-1 in the cRCC group [0.724 ± 1.120 ng/mg 
urinary creatinine  (Ucr)] were significantly greater compared with 
controls (healthy volunteers) (0.210 ± 0.082 ng/mgUcr) 
(p = 0.0227). Postoperatively, uKIM-1 concentration decreased 
significantly to control values (0.177 ± 0.099 ng/mgUcr vs 0.210 
± 0.082 ng/mgUcr, respectively). The size, grade and stage of 
tumor were correlated positively with preoperative uKIM-1 con-
centrations. Contrary to these results, concentrations of uAQP-1 
in the cRCC group were significantly lower (0.111 ± 0.092 
ng/mgUcr) compared with the control group (0.202 ± 0.078 
ng/mgUcr) (p = 0.0014). Postoperatively, the concentrations of 
uAQP-1 increased progressively up to control values, approxi-
mately. We find no significant correlation between preoperative 
uAQP-1 concentrations and tumor size, grade and stage. Conclu-
sion. uKIM-1 was found to be a reliable diagnostic marker of 
cRCC, based on its significantly increased values before and de-
creased values after the nephrectomy. 
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Apstrakt 
 
Uvod/Cilj. Molekul oštećenja bubrega-1 (KIM-1) i ak-
vaporin-1 (AQP-1) su potencijalni rani biomarkeri karci-
noma svetlih ćelija (cRCC). Cilj ove studije bio je da se ut-
vrdi povezanost između koncentracija KIM-1 i AQP-1 u ur-
inu i veličine, gradusa, stadijuma i vrste operacije (radikalna 
ili parcijalna nefrektomija) kod bolesnika sa cRCC. Metode. 
Urinarne koncentracije KIM-1 i AQP-1 određene su pri-
menom komercijalnih ELISA kitova. Analizom je bilo 
obuhvaćeno 40 bolesnika koji su bili podvrgnuti parcijalnoj 
ili radikalnoj nefrektomiji zbog tumora bubrega i 40 zdravih 
odraslih ispitanika. Grupe su bile komparabilne po polu i 
godinama života. Rezultati. Srednja preoperativna koncen-
tracija urinarnog KIM-1 (uKIM-1) u cRCC grupi [0,724 ± 
1,120 ng/mg kreatinia u urinu (Ucr)] bila je statistički znača-
jno viša u poređenju sa koncentracijom u kontrolnoj grupi 
(0,210 ± 0,082 ng/mgUcr ) (p = 0,0227). Postoperativno, 
koncentracija uKIM-1 značajno je padala i približavala se 
vrednosti u kontrolnoj grupi (0,177 ± 0,099 ng/mgUcr 
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nasuprot 0,210 ± 0,082 ng/mgUcr). Veličina, gradus i stadi-
jum tumora bili su u pozitivnoj korelaciji sa preoperativnim 
koncentracijama uKIM-1. Nasuprot ovim rezultatima, kon-
centracija urinarnog AQP-1 (uAQP-1) u cRCC grupi bila je 
značajno niža (0,111 ± 0,092 ng/mgUcr) u poređenju sa 
kontrolnom grupom zdravih osoba (0,202 ± 0,078 
ng/mgUcr) (p = 0,0014). Postoperativno, koncentracija 
uAQP-1 progresivno se povećavala, približno do vrednosti 
u kontrolnoj grupi. Nismo našli značajnu korelaciju između 
preoperativnih koncentracija uAQP-1 i veličine, gradusa i 
stadijuma tumora. Zaključak. uKIM-1 bi mogao biti do-
datni pouzdani dijagnostički marker za cRRC na osnovu 
njegove značajno više preoperativne koncentracije i sniženja 
vrednosti nakon nefrektomije. 
 
Ključne reči: 
bubreg, neoplazme; dijagnoza; biološki pokazatelji; 
mokraća; nefrektomija. 
 
Introduction 
Renal cell carcinoma (RCC) represents approximately 
3.8% of all malignancies in adults, increasing permanently 
over the past 30 years by 2−4% per year 1. The most com-
mon and also the most aggressive form of RCC is clear re-
nal cell carcinoma (cRCC), often characterized by the lack 
of early symptoms, signs and laboratory abnormalities. For 
these reasons cRCC is most often diagnosed accidentally 
during abdominal imaging performed for unrelated diagno-
stic reasons. Consequently, at the time of diagnosis, one-
third of patients are already at metastatic stage of the disea-
se 2. Thus, reliable marker for cRCC should be powerful 
tool in screening patients for this particular type of the tu-
mor and additionally, it could be used for monitoring of re-
sponse to therapy and for the post-treatment surveillance, 
as well. 
Recently, elevated urine concentrations of kidney injury 
molecule-1 (uKIM-1) and aquaporin-1 (uAQP-1) in patients 
with cRCC were recognized as specific and sensitive early 
markers of the disease 3. KIM-1 is a type I transmembrane 
protein, whose ectodomain is secreted into urine in a respon-
se to the damage of the proximal tubule 4. It has been shown 
that up regulation of KIM-1 in tumor cells is caused by de-
differentiation of cells of the proximal tubules, such as cRCC 
and papillar renal cell carcinoma (pRCC). Patients with 
histologically confirmed cRCC have significantly higher 
concentration of uKIM-1 in pre-surgery phase, as compared 
with healthy individuals 5. Current studies are focused on po-
tential usage of levels of uKIM-1 for the early diagnosis of 
cRCC and possibility of preoperative determination of the 
RCC type 6, 7. Aquaporin-1 (AQP-1) is a water channel 
expressed in many epithelial tissues and endothelium, inclu-
ding the proximal tubule of the kidney 8. More recently, the 
diagnostic and prognostic usefulness of AQP-1 has been tes-
ted in cRCC tissues by using microarray techniques showing 
a reduction of AQP-1 expression in cRCC, as compared to 
normal renal tissue. A general decrease of AQP-1 protein can 
be related to the loss of differentiation, which is more prono-
unced in higher grade tumor 9. Contrary to the above histo-
pathological findings, recent studies have shown elevated 
uAQP-1 concentrations, determined by specific Western blot 
analysis in patients with cRCC 10−12. 
The aim of this study was to determine if uKIM-1 and 
uAQP-1 concentrations in cRCC diagnosed patients under-
going partial or radical nephrectomy are related to tumor si-
ze, grade, and pT stage. 
Methods 
Patients 
KIM-1 and AQP-1 were measured in urine samples of 
40 patients submitted to radical or partial nephrectomy of re-
nal tumor and in urine samples of 40 healthy adult volunte-
ers. The study was conducted by our Institution between 
September 2012 and August 2013 and it was approved by the 
Ethical Committee of the Military Medical Academy, Bel-
grade, Serbia. Written and informed consent was obtained 
from each participant. All patients were preoperatively sta-
ged by thoracoabdominal multislice computed tomography 
(MSCT) imaging. The preoperative estimated glomerular fil-
tration rates (GFR) − eGFR were calculated using the Chro-
nic Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation 13. The patients with a GFR less than 60 
mL/min/1.73 m2 and/or the history of previous renal and ma-
lignant diseases were not included. For each patient/healthy 
volunteer, the following variables were obtained from the 
medical records: gender, age, comorbidities that could influ-
ence the baseline level of markers, baseline serum creatinine, 
eGFR and the type of surgery (partial or radical 
nephrectomy). A radical or partial nephrectomy was perfor-
med by open approach. The postoperative pathology reports 
provided tumor type, size according to the largest dimension, 
tumor-node-metastasis (TNM) stage and Fuhrman grade. 
The study included only patients with the diagnosis of cRCC 
categorized according to the American Joint Committee on 
Cancer 2010 TNM staging system 14. 
Sample collection 
Voided urine samples were aseptically collected 
preoperatively and on the day 7 and 30 after the operation. 
All fresh samples were immediately processed within four 
hours of collection to ensure optimal protein stability. Urine 
was centrifuged (1,800 g, 10 min) to remove debris, dividing 
into 1.5 mL aliquots and frozen at -80°C until analysis. Pre-
operative blood samples were also collected to measure se-
rum creatinine. Patients’ venous blood was drawn by trained, 
qualified flebotomists. The levels of uKIM-1 and uAQP-1 
were determined by commercially available ELISA kits 
(ELISA, TIM-1/KIM-1/HAVCR, R&D Systems Inc, Minne-
apolis, MN, USA and AQP1 (Human) ELISA Kit, Abnova, 
Heidelberg, German), respectively. The absolute values 
(pg/mL) of uKIM-1 and uAQP-1 were calculated per norma-
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Table 1 
Clinical and pathological characteristics of the examined participants 
Parameter cRCC group (n = 40) 
Control group 
(healthy volunteers) 
(n = 40) 
Gender, (male/female), n 25 / 15 22 / 18 
Age (years), ґ ± SD 56.24  ±  11.73 60.45  ±  18.12 
GFR (mL/min/1.73m2), ґ ± SD 87.49  ±  16.46 88.82  ±  18.39 
Tumor dimension (cm), ґ ± SD  5.50  ±  3.05 / 
Grade, n  G1 = 0 
G2 = 30 
G3 = 9 
G4 = 1 
/ 
TNM stage, n I = 22 
II = 3 
III = 13 
IV = 2 
/ 
cRCC – clear renal cll carcinoma; GFR – glomerular filtration rate; TNM – tumor-node-metastasis. 
lized urinary creatinine (Ucr) to avoid variability in urine 
flow and the results were expressed in ng/mgUcr. The mini-
mum detectable dose for uKIM-1 and uAQP was 0.009 
ng/mL and 0.04 ng/mL, respectively. 
Creatinine determination 
Serum and urine creatinine concentrations were measu-
red by the modified Jaffe method using Siemense Dimension 
Rxl Max chemistry analyzer. 
Statistics 
Statistical software GraphPad Prism 5.0 was used for 
statistical analysis. After determining basic parameters of de-
scriptive statistical analysis [mean value (ґ), standard devia-
ton (SD), median (med), standard error of the mean (SEM)] 
we have analyzed Gaussian distribution of data with Kolmo-
gorov Smirnov test. Data from multiple groups were compa-
red with one way analysis of variance with Bonferroni mul-
tiple post-testing comparison. Nonparamteric Mann Whitney 
(MW) test was used to compare the differences between the 
two groups, where needed, while serial data from each pati-
ent in different time points were compared as paired data 
with Wilcoxon test. 
Results 
The clinical and pathological characteristics of the studi-
ed participants are shown in Table 1. In the cRCC group 
(n = 40) we measured uKIM-1 and uAQP-1 before surgery in 
all participants, in 37 (92.5%) patients on the postoperative 
day 7 and in 23 (57.5%) patients on the postoperative day 30. 
Urine samples on the day 30 after the operation were not avai-
lable from 14 patients with cRRC because they did not come 
to follow-up visit. The control group included 40 healthy vo-
lunteers (n = 40). The cRCC group and the control group did 
not differ significantly according to age, sex and eGFR. The 
pathologic tumor size for the cRCC group was 5.50 ± 3.05 cm 
(ґ ± SD). The distribution of the pathologic stage was as 
follows: pT1a in 13 (32.5%), pT1b in 10 (25%), pT2a in 3 
(7.5%), pT3a in 14 (35%) and there was no patients in pT4. 
The postoperative TNM stage was as follows: stage I in 22, 
stage III in 13 and only 3 and 2 patients in stage II and IV, 
respectively. The classification according to the Fuhrman gra-
de was: 30 (75%) patients with grade 2; 9 (22.5%) patients 
with grade 3; and 1 (2.5%) patient with grade 4. None of the 
patients had tumor grade 1 and positive lymph nodes. Two pa-
tients had metastases in the lung preoperatively.  
The median pre- and postoperative uKIM-1 concentra-
tions are listed in Table 2. 
The median preoperative concentration of uKIM-1 in the 
cRCC group (0.724 ± 1.120 ng/mgUcr) was significantly grea-
ter compared with that in the control group (0.210 ± 0.082 
ng/mgUcr, p = 0.0227) (Figure 1). The postoperative uKIM-1 
concentration decreased significantly on the first postoperative 
control visit (0.327 ± 0.225 ng/mgUcr) compared with the 
preoperative concentration. On the second control visit the 
concentration of uKIM-1 in the cRCC group was statistically 
indistinguishable from the control group (0.177 ± 0.099 
ng/mgUcr vs 0.210 ± 0.082 ng/mgUcr, respectively) (Table 2).  
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Fig. 1 − uKIM-1 in urine samples of the cRCC patients 
and the healthy volunteers. 
For abbreviations see Table 2. 
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Table 2 
Urinary kidney injury molecule-1 (uKIM-1) and urinary aquaporin-1 (uAQP-1) in the examined patients with 
clear renal cell carcinoma (cRCC) 
uAQP-1 
(ng /mg creatine), ґ ± SD 
uKIM-1 
(ng /mg creatine), ґ ± SD Parameter 
before 
operation I control visit II control visit
before
operation I control visit II control visit
0.111 ± 0.092 0.153 ± 0.163 0.212 ± 0.201 0.724 ± 1.120 0.327 ± 0.225 0.177 ± 0.099
Fuhrman gradus
G1 none none none none none none 
G2 0.110 ± 0.097 0.113 ± 0.068 0.202 ± 0.172 0.409 ± 0.503 0.326 ± 0.225 0.170 ± 0.096
G3 0.113 ± 0.080 0.287 ± 0.293 0.237 ± 0.283 1.852 ± 2.146 0.339 ± 0.248 0.190 ± 0.112
Tumor size, cm 
≤ 4  0.141 ± 0.115 0.119 ± 0.072 0.267 ± 0.298 0.293 ± 0.169 0.357 ± 0.206 0.246 ± 0.124
4.1−7 0.073 ± 0.035 0.110 ± 0.069 0.205 ± 0.064 0.278 ± 0.139 0.307 ± 0.209 0.133 ± 0.033
>7  0.099 ± 0.075 0.261 ± 0.284 0.123 ± 0.105 2.092 ± 2.116 0.342 ± 0.300 0.153 ± 0.096
TNM stage
I 0.117 ± 0.109 0.117 ± 0.072 0.210 ± 0.205 0.259 ± 0.133 0.319 ± 0.217 0.189 ± 0.113
II 0.129 ± 0.108 0.131 ± 0.058 0.000 ± 0.000 0.383 ± 0.075 0.380 ± 0.308 0.095 ± 0.029
III 0.099 ± 0.059 0.212 ± 0.248 0.224 ± 0.215 1.623 ± 1.924 0.347 ± 0.249 0.181 ± 0.100
Surgery type
partial nephrectomy  0.126 ± 0.137 0.074 ± 0.047 0.160 ± 0.101 0.202 ± 0.118 0.327 ± 0.314 0.225 ± 0.164
radical nephrectomy   0.107 ± 0.078 0.173 ± 0.176 0.226 ± 0.222 0.917 ± 1.456 0.204 ± 0.226 0.138 ± 0.087
Note: The concentration uAQP-1 in the healthy volunteers before operation were 0.202 ± 0.079 µ/mg urinary creatinine (Ucr) and 
0.210 ± 0.082 ng/mg Ucr, respectively.  
TNM – tumor-node-metastasis. 
       Table 3 
Correlation analysis between uKIM-1 and uAQP-1 and tumor size, 
Fuhrman gradus, tumor pathological stage and TNM grade
Analyse vs parameter R coefficient p 
uKIM1 (0) Tu (cm) +0.564 0.00004 
uKIM1 (0) Tu (pT std) +0.512 0.00085 
uKIM1 (0) G (Fuhrman) +0.490 0.00064 
uKIM1 (0) TNM +0.580 0.00005 
uAQP-1 (0) Tu (cm) -0.112 > 0.05 
uAQP-1 (0) Tu (pT std) -0.151 > 0.05 
uAQP-1 (0) G (Fuhrman) +0.024 > 0.05 
uAQP-1 (0) TNM +0.042 > 0.05 
For abbreviations see Table 2. 
There was a positive correlation between preoperative 
uKIM-1 concentration and tumor size, grade and stage (Table 
3). The preoperative uKIM-1 concentration in the patients with 
cRCC correlated positively with tumor size, based on 
maximum tumor dimension. The mean uKIM-1 concentration 
in the group of patients with tumors larger than 7 cm was 
significantly higher (p = 0.0008) compared with the mean 
concentration of uKIM-1 in the patients with the tumor size of 
4.1−7 cm and/or less and equal to 4 cm (p = 0.0004) (Figure 2). 
In addition, a positive correlation was obtained between the 
concentration of uKIM-1 and tumor grade (p = 0.00075). 
The patients with high-grade tumors had a higher 
uKIM-1 level compared with those who had low-grade lesi-
ons (1.852 ± 2.146 ng/mgUcr vs 0.409 ± 0.503 ng/mgUcr), 
respectively (Table 2) and these differences were statistically 
significant (p = 0.0003) (Figure 3).  
The preoperative mean values of uKIM-1 were 
significantly higher in patients with TNM stage III than with 
stage I (p < 0.0001, MW test) (Figure 4). The elevated baseline 
uKIM-1 (1.623 ± 1.924 ng/mgUcr) was significantly reduced 
to 0.347 ± 0.249 ng/mgUcr on the first control visit after the 
operation in patients with stage TNM III. In the patients with 
stage TNM I and TNM II, a significant reduction of uKIM-1 
occurred only at the second control after the surgery.  
It was shown that the type of surgery, partial or radical, 
had an impact on the concentration of uKIM-1, based at the 
first postoperative control visit. Before surgical intervention, 
the median uKIM-1 value was significantly higher in the 
group that later had radical resection compared to the partial 
resection group (p = 0.0044) (Figure 5). Contrary, on the first 
control examination uKIM-1 concentration was higher in the 
partial resection group than in the those who had radical re-
section. On the second control examination the average 
uKIM-1 value did not differ significantly regardless of the 
type of surgery. 
Interestingly, analysis of uAQP-1 levels after adjus-
tment to urinary creatinine (Ucr) concentration showed 
completely different dynamics compared to uKIM-1. In pati-
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ents with cRCC, uAQP-1 was significantly lower (0.111 ± 
0.092 ng/mgUcr) than in the control group (0.202 ± 0.078 
ng/mgUcr) (p = 0.0014). Postoperatively, the concentration 
of uAQP-1was progressively increasing and on the second 
control achieved approximately the same value as the control 
group (Table 2). We find no significant correlation between 
the preoperative uAQP-1 concentration and the tumor size, 
grade and stage (Table 3).  
Discussion 
The widespread use of modern radiological techniques 
such as ultrasound, computed tomography (CT) and magne-
tic resonance imaging (MRI) performed for unrelated diag-
nostic reasons has increased the diagnosis of renal tumors, 
especially tumors of smaller size detected incidentally 15, 16. 
Although, preoperative needle biopsy of small lesion (≤ 3 
cm) is followed by a relatively high sensitivity and 
specificity for the diagnosis of RCC, it carries a risk of false 
negative results and complications such as hematuria, subca-
psular/perinephric hematoma and spread of malignant cells 17. 
Sensitive and specific marker of the tumor needs to be able 
to predict certain type of cancer and also to monitor disease 
after treatment. 
In order to determine the nature of preoperative tumor 
changes in the kidney and optimal treatment, we investigated 
urinary concentrations of KIM-1 and AQP-1 as a potential 
diagnostic marker for CRCC. 
The results of our study showed that the preoperative 
concentrations of uKIM-1 in the patients with cRCC were 
statistically significantly higher than the value of postopera-
tive uKIM-1 and than in the control group of healthy volun-
 
 
Fig. 2  − uKIM-1 according to tumor size. 
For abbreviations see Table 2. 
 
Fig. 3 – uKIM-1 according to Fuhrman grade.  
For abbreviations see Table 2. 
 
 
Fig. 4 – uKIM-1 according to TNM stage.  
For abbreviations see Table 2. 
 
 
 
Fig. 5 − uKIM-1 according to the applied surgery type (
partial nephroctomy and 2- radical nephroctomy). 
For abbreviations see Table 2. 
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teers. After resection of the renal tumor using either partial 
or radical nephrectomy, uKIM-1 concentrations decreased to 
the levels essentially equivalent to that of the controls. Simi-
lar findings were reported by Han et al. 5. Morrissey et al. 3 
and Zhang et al. 7 indicating significantly higher preoperative 
uKIM-1 concentration in patients with cRCC compared with 
the patients with non-cRCC. Accordingly to Han et al. 5 and 
Morrissey et al. 11 we also found a positive correlation 
between tumor volume and uKIM-1 level. A different obser-
vation was reported by Shalabi et al. 18 who found no corre-
lation between the concentration uKIM-1 and the size of the 
tumor, which might be explained by the fact that the most of 
the patients had tumor of small size (4.57 ± 0.37 cm). Zhang 
et al. 7 also found no correlation between uKIM-1 and the si-
ze of the tumor. 
Tumor size is associated with malignant potential in 
RCC. A study of Thompson et al. 19 shows that the risk of 
malignancy of tumor and the percentage of high nuclear gra-
de increases with the size of the tumor. Our study shows that 
the prevalence of high nuclear grade tumors increases with 
the tumor size. Thus, in the group with tumor ≤ 4 cm in dia-
meter the prevalence of high grade tumor (G3 and G4) was 
7.14%, in the group with tumor of 4.1−7 cm in diameter it 
was 17.64%, while in the group with tumor of > 7 cm in di-
ameter the prevalence was 60%. The data we obtained 
showed a positive correlation between the size of the tumor 
and the nuclear grade.  
In our study, the highest percentage of patients had G2 
(75.61%) and G3 (21.95%) tumor grade, whereas only one 
patient had grade G4 (2.44%). None of the patients had G1 
tumor grade. A similar distribution of Furman grade was fo-
und by other authors 20, 21. In our study, a positive correlation 
was obtained between concentration of uKIM-1 and tumor 
grade. Different results were observed by Shalabi et al. 18 
who found no correlation between uKIM-1 and tumor grade. 
Statistical analysis showed a different time course profile of 
uKIM-1 depending on the grade of the tumor. In the group of 
G3 grade operations induced a significant decrease of uKIM-
1 on the first control examination, which later retained 
virtually the same level. In the group with G2 grade there 
was a significant decrease in uKIM-1 only between the first 
and the second control examination. A possible explanation 
for these results lies in the fact that the secretion of KIM-1 
was independent of the tumor. Specifically, all eight patients 
who were submitted to a partial nephrectomy had G2 grade 
of the tumor. Obviously, after the surgery the recovery pro-
cess resulted in elevated uKIM-1 because of renal ischemic 
injury during partial nephrectomy. The same result was obta-
ined by Morrissey et al. 3 who confirmed a significantly 
lower reduction in postoperative uKIM-1 in patients with 
partial nephrectomy than in patients submitted to radical 
nephrectomy.  
Partial nephrectomy is the optimal therapeutic modality 
of treatment in most patients with organ-confined RCC, ac-
hieving good disease control with preservation of renal func-
tion. Chronic Kidney Disease Prognosis Consortium Mat-
sushita et al. 22 showed that the reduction of GFR below 60 
mL/min/1.73m2 is an independent predictor of total and car-
diovascular mortality. To our knowledge, a study of Abassi 
et al. 23 is the only one comparing uKIM-1 before and after 
partial nephrectomy at different time intervals in 27 patients 
with RCC. A significant increase of uKIM-1 was registered 
from 3 to 24 hours after ischemic injury. In our study avera-
ge concentrations of uKIM-1 at the first control examination 
on the postoperative day 7 was almost twice as high in the 
group of patients with partial nephrectomy compared to the 
group with a radical nephrectomy, but it did not reach statis-
tical significance. This result was expected because the 
kidney still has been in the process of recovering at the time 
of the first control. Average uKIM-1 values did not differ 
significantly on the second control examination on the  pos-
toperative day 30, regardless of the applied intervention type, 
partial nephrectomy or radical nephrectomy, confirming acu-
te ischemic renal damage. In addition, the patients subjected 
to radical nephrectomy had statistically significant higher 
uKIM-1 before the operation than the group subjected to par-
tial nephrectomy. This result is a consequence of the larger 
size and higher-nuclear grade and stage of the tumor in the 
radical nephrectomy group. We showed that the uKIM-1 
directly correlates with pathological characteristics of tumor.  
Interestingly, in contrary to uKIM-1, analysis of uAQP-
1 levels after adjustment to Ucr concentration showed a 
completely different dynamics during examination period. At 
first, the concentration uAQP-1 was significantly lower in 
the cRCC group than in the group of healthy subjects. Altho-
ugh a nonstatistically significant correlation was found 
between uAQP-1 and the size, stage or grade of the tumor, 
we observed slightly lower but not significant levels of this 
biomarker in patients with more aggressive grade (III–IV) 
and larger (> 7 cm) tumors.  
In contrast to our results, Morrissey et al. 11 showed a 
direct correlation between the concentration uAQP-1 (deter-
mined by Western blot analysis) and the size and stage, but 
not the grade of the tumor. Similarly, Morrissey et al. 11 Sre-
edharan et al. 12 found a strong positive correlation between 
uAQP-1 and cRCC in 11 patients before operation. But, due 
to the small number of patients in their study correlation 
between the concentration uAQP-1 and pathological charac-
teristics of the tumor was not performed 12. Unlike previous 
studies in which the concentration of uAQP-1 was determi-
ned by Western blot analysis, we used commercial ELISA 
test to quantify the concentration uAQP-1, for the first time, 
to our knowledge.  
Our results are complementary to the results of the hi-
stopathological study of the expression of AQP-1 in cRCC 
tissue. Ticozzi-Valerio et al. 24 showed a reduction of AQP-
1 expression in tissue of cRCC from moderate to almost 
complete, depending on tumor grade. Tumor with high gra-
de had a higher reduction of tissue AQP-1 expression com-
pared to normal kidney tissue. Mazal et al. 25 proved a signi-
ficant reduction or loss of AQP-1 expression in higher nuc-
lear grade cRCC compared with those of lower grade, 
while there was no significant correlation accomplished 
between pT stage and expression of AQP-1. Unfortunately, 
we were not able to determine the expression of AQP-1 in 
the tumor tissue. 
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Conclusion 
In summary, uKIM-1 but not uAQP-1 was statistically 
and clinically significantly increased in the patients with 
cRCC compared to the group of healthy subjects. Taking into 
the consideration the type of sample used for KIM-1 measu-
rement (urine is a sample of choice what implies noninvasive 
sampling, simplicity and commitment of uKIM-1 measure-
ments by using a commercial ELISA kit, mainly literature 
supported), we concluded that uKIM-1 might be used as a 
valuable and reliable biomarker of cRCC diagnosis and for 
monitoring patients with cRCC after operation, in routine 
clinical practice. 
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